<DOC>
	<DOCNO>NCT00432198</DOCNO>
	<brief_summary>To investigate efficacy safety zolpidem pediatric insomniac randomize double blind-controlled trial</brief_summary>
	<brief_title>Zolpidem Postmarketing Study Adolescent Patients With Insomnia</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>patient diagnose nonorganic insomnia nonorganic sleep disorder ICD10 patient whose age time obtain consent 12 year 18 year patient schizophrenia manicdepressive illness patient insomnia caused physical disease patient history hypersensitivity zolpidem patient attentiondeficit hyperactivity disorder</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Insomnia</keyword>
	<keyword>Zolpidem</keyword>
	<keyword>Adolescent</keyword>
</DOC>